Aumolertinib Combined With Phased Chemotherapy for EGFR L858R Lung Adenocarcinoma

Clinical trial NCT07624487 · RECRUITING

Trial details

NCT number: NCT07624487
Sponsor: Taipei Medical University Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Adenocarcinoma Metastatic

Start date: 2026-06-09
Primary completion: 2028-12-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.